At AstraZeneca, an early adopter of AI and data science for healthcare, these tools are helping scientists in their quest to find life-changing new treatments for some of the world's most ...

Sales in AstraZeneca's top business, oncology, grew 19% at constant currency rates to $5.33 billion and accounted for 41% of the total, while its rare disease and heart and kidney disease ...

AstraZeneca is an established leader in respiratory care with a 50-year heritage and a growing portfolio of medicines in immune-mediated diseases. The company is committed to addressing the vast unmet ...

Some drugmakers are taking the unusual step of sending more medicines by air to the U.S., two executives and two logistics firms said amid fears that President Donald Trump's Wednesday tariffs ...